Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma
- PMID: 12515714
- DOI: 10.1182/blood-2002-11-3387
Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma
Abstract
The BCL6 proto-oncogene encodes a transcriptional repressor whose expression is deregulated by chromosomal translocations in approximately 40% of diffuse large B-cell lymphomas (DLBCLs). The BCL6 regulatory sequences are also targeted by somatic hypermutation in germinal center (GC) B cells and in a fraction of all GC-derived lymphomas. However, the functional consequences of these mutations are unknown. Here we report that a subset of mutations specifically associated with DLBCL causes deregulated BCL6 transcription. These mutations affect 2 adjacent BCL6 binding sites located within the first noncoding exon of the gene, and they prevent BCL6 from binding its own promoter, thereby disrupting its negative autoregulatory circuit. These alterations were found in approximately 16% of DLBCLs devoid of chromosomal translocations involving the BCL6 locus, but they were not found in normal GC B cells. This study establishes a novel mechanism for BCL6 deregulation and reveals a broader involvement of this gene in DLBCL pathogenesis.
Similar articles
-
BCL-6 in diffuse large-cell lymphomas.Important Adv Oncol. 1996:139-48. Important Adv Oncol. 1996. PMID: 8791133 Review. No abstract available.
-
Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.Haematologica. 2004 Sep;89(9):1091-9. Haematologica. 2004. PMID: 15377470
-
BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma.Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11294-9. doi: 10.1073/pnas.0903854106. Epub 2009 Jun 23. Proc Natl Acad Sci U S A. 2009. PMID: 19549844 Free PMC article.
-
[Bcl-6: a protooncogene co-involved in B-lymphocyte differentiation and in the pathogenesis of diffuse, large-cell non-Hodgkin's lymphomas of the B phenotype].Pathologica. 1998 Feb;90(1):81-2. Pathologica. 1998. PMID: 9628984 Review. Italian. No abstract available.
-
The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.Cell Growth Differ. 1995 Dec;6(12):1495-503. Cell Growth Differ. 1995. PMID: 9019154
Cited by
-
STAT6-mediated BCL6 repression in primary mediastinal B-cell lymphoma (PMBL).Oncotarget. 2013 Jul;4(7):1093-102. doi: 10.18632/oncotarget.1149. Oncotarget. 2013. PMID: 23852366 Free PMC article.
-
POZ-, AT-hook-, and zinc finger-containing protein (PATZ) interacts with human oncogene B cell lymphoma 6 (BCL6) and is required for its negative autoregulation.J Biol Chem. 2012 May 25;287(22):18308-17. doi: 10.1074/jbc.M112.346270. Epub 2012 Apr 9. J Biol Chem. 2012. Retraction in: J Biol Chem. 2017 Mar 31;292(13):5609. doi: 10.1074/jbc.A117.346270 PMID: 22493480 Free PMC article. Retracted.
-
Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas.Blood. 2008 Feb 1;111(3):1515-23. doi: 10.1182/blood-2007-04-087734. Epub 2007 Oct 19. Blood. 2008. PMID: 17951530 Free PMC article.
-
Reciprocal negative regulation between the tumor suppressor protein p53 and B cell CLL/lymphoma 6 (BCL6) via control of caspase-1 expression.J Biol Chem. 2019 Jan 4;294(1):299-313. doi: 10.1074/jbc.RA118.004204. Epub 2018 Nov 8. J Biol Chem. 2019. PMID: 30409904 Free PMC article.
-
Triple Lymphoma and Transformation to Diffuse Large B-Cell Lymphoma Finding at the Time of Diagnosis.Cureus. 2023 Aug 23;15(8):e43971. doi: 10.7759/cureus.43971. eCollection 2023 Aug. Cureus. 2023. PMID: 37746409 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous

